Oxygen as a Limiting Factor for Performing Multitasking
NCT ID: NCT03126669
Last Updated: 2024-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2014-11-01
2017-03-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Cognitive Enhancement During Hyperbaric Oxygen Treatments
NCT04358796
Cognitive Profile of Patients at the Sagol Center for Hyperbaric Medicine and Research
NCT04287283
Treatment of Traumatic Brain Injury With Hyperbaric Oxygen Therapy
NCT00810615
Hyperbaric Oxygen Therapy for Mild Cognitive Impairment
NCT02085330
Hyperbaric Oxygen Therapy Improves Brain Function in Patients With Cognitive Decline After COVID-19 Infection.
NCT05715801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the present study was to evaluate whether hyperbaric oxygen (HBO) environment, with increased oxygen supply to the brain, will enable better performance of complex and/or multiple activities.
Methods: a prospective, double blind randomized control, cross over trial including healthy volunteers. Participants were asked to perform a cognitive task, a motor task and a simultaneous cognitive-motor task (multi-tasking). Participants were randomized to perform the tasks at 2 environments: (a) normobaric air (1ATA 21% oxygen) (b) HBO (2ATA 100% oxygen). Two weeks later participants were crossed to the alternative environment. Blinding of the normobaric environment was achieved in the same chamber with masks on while hyperbaric sensation was simulated by increasing pressure in the first minute and gradually decreasing to normobaric environment prior to tasks performance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treratment
100% oxygen at 2 ATA at the hyperbaric chamber
Hyperbaric oxygen
Breathing 100% oxygen at 2ATA in the hyperbaric chamber
Placebo
normal air, in the hyperbaric chamber
Hyperbaric chamber, normal air
Hyperbaric chamber with normal air
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyperbaric oxygen
Breathing 100% oxygen at 2ATA in the hyperbaric chamber
Hyperbaric chamber, normal air
Hyperbaric chamber with normal air
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* minimum of 12 years of formal education
Exclusion Criteria
* any lung disease,
* any mental or physical limitation of participat in going into oxygen chamber environment
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assaf-Harofeh Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shai a Efrati, MD
Role: PRINCIPAL_INVESTIGATOR
Asaf-Harofhe MC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assaf-Harofeh Medical Center
Ẕerifin, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
213/13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.